ClinicalTrials.govpublic full text
A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma
cancer, relapsed/refractory large b-cell lymphoma (lbcl)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 366599
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.